AGM, page-33

First 33 Last

Share
Profile

Follow
bhoulahan

534 Posts.

30

27/11/17

18:21

Post #: 29155454
Share

Originally posted by F18FDG ↑

What in the opinion of yourself -and others is the viability of VLA going it alone? Zip, zilch, nada, none. Not gonna happen. Monotherapy evidence supports the combination clinical and business case only.

dragging their feet to allow possible competition to catch -up as it were etc etc I have commented extensively on this oft-held but, imho, utterly delusional perspective.

If CVA21 could assist (say) Yervoy in moving from the very real position of an also-ran in the I/O space (running at a bit more than half of analysts 2013 estimates), into a rejuvenated therapy, that could easily be worth an additional $500m/year in sales within a year or 2. It seems logical the imperative is when, not how much.

To think there would be some conspiracy and market manipulation in play to slow down the uptake of CVA21 in a Yervoy combo (say) so competitors would catch up and somehow force the price down (by what a couple hundred $m?) defeats logic and all commercial sensibility.

I refer you to the case of Unilife OK, Unilife was a me-too wannabe in a crowded space run by an individual known to have a 'colourful past' (HC TOU prevent me from offering my real opinion). I pity investors caught out there, but there isn't much comparison to VLA, IMO.

Expand

I hope not - lost my shirt on UNI

VLA Price at posting: 64.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SVL

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

Emerald & Azure score Digger & Dealer awards

ARD

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

VTM

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

IMD

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

M2R

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Bitcoin: Current State of Play & Where to Next | Swyftx

WNX

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

EQR

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

There are more pages in this discussion • 7 more messages in this thread...

First 33 Last

Add VLA (ASX) to my watchlist

AGM, page-33

Top Stories

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

Emerald & Azure score Digger & Dealer awards

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Bitcoin: Current State of Play & Where to Next | Swyftx

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

Featured News